Skip to main content

Maria Cristina Centeno Mediavilla

Institutions of which they are part

Senior researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Maria Cristina Centeno Mediavilla

Institutions of which they are part

Senior researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Projects

Targeting Myeloid-Derived Suppressor Cells to prevent HIV/STI acquisition

IP: Meritxell Genesca Ferrer
Collaborators: Maria Cristina Centeno Mediavilla, Nuria Laia Rodriguez Mias, Yannick Hoyos Mallecot, Josep Castellví Vives, Laura Mañalich Barrachina, María José Buzón Gómez, Maider Arando Lasagabaster, Bibiana Planas Ribas, Targeting Myeloid-Derived Suppressor Cells to prevent HIV/STI acquisition
Funding agency: Fundació La Marató de TV3
Funding: 199685
Reference: 20181410
Duration: 10/05/2019 - 31/12/2022

Caracterización de los reservorios VIH latentes del tejido cervical y nuevas estrategias para eliminarlos

IP: Meritxell Genesca Ferrer
Collaborators: Vicenç Falcó Ferrer, Maria Cristina Centeno Mediavilla
Funding agency: Instituto de Salud Carlos III
Funding: 111320
Reference: PI17/01470
Duration: 01/01/2018 - 31/12/2021

Desarrollo de una herramienta de diagnóstico precoz de cáncer de endometrio en biopsia líquida cervical

IP: Eva Colas Ortega
Collaborators: Vicente Bebia Conesa, Maria Cristina Centeno Mediavilla, Silvia Franco Camps, Silvia Cabrera Diaz
Funding agency: Instituto de Salud Carlos III
Funding: 93170
Reference: PI17/02155
Duration: 01/01/2018 - 30/06/2022

STELLA trial: Ensayo clínico randomizado comparando la via de abordaje de la linfadenectomía aórtica laparoscópica: via transperitoneal vs extraperitoneal en cáncer de endometrio y ovario

IP: -
Collaborators: Maria Cristina Centeno Mediavilla, Fco Javier De la Torre Fdez de Vega, Silvia Franco Camps, Montserrat Cubo Abert
Funding agency: Instituto de Salud Carlos III
Funding: 36905
Reference: PI14/01817
Duration: 01/01/2015 - 30/06/2019

Related news

Researchers from the centre took part in international debates on AI in healthcare, spin-offs emerging from research were presented, and several initiatives linked to VHIR received recognition in the field of entrepreneurship.

The grants promote new therapeutic strategies and diagnostic tools in highly complex tumors such as glioblastoma, triple-negative breast cancer, and endometrial cancer.

The Department of Health of the Generalitat de Catalunya grants subsidies for carrying out validation tests on innovative projects in the field of health that are in the early stages of development.

Related professionals

Judith Martínez Lacambra

Judith Martínez Lacambra

Tècnic de recerca
Clinical Trials Management Unit
Clinical Research Development Directorate
Read more
María Garrido Martínez

María Garrido Martínez

Gestió i Administració
Innovation Unit
Directorate of Innovation and Business Development
Read more
Romina Dieli Crimi

Romina Dieli Crimi

Senior researcher
Translational Immunology
Read more
Imane Boutitah Benyaich

Imane Boutitah Benyaich

Predoctoral researcher
Clinical Neuroimmunology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.